Gainers
- Protagonist Therapeutics, Inc. (NASDAQ:PTGX) shares surged 85% to $33.78. The FDA removed the full clinical hold on Protagonist Therapeutics’ rusfertide clinical studies. Northland Capital Markets upgraded the stock from Market Perform to Outperform.
- Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) gained 74% to $8.04. Supernus Pharmaceuticals agreed to acquire Adamas Pharmaceuticals for $9.10 per share, or $450 million.
- Flexion Therapeutics, Inc. (NASDAQ:FLXN) gained 60.9% to $9.30. Pacira BioSciences agreed to acquire Flexion Therapeutics for $8.50 per share in cash, plus one contingent value right (CVR) worth up to $8.00 per share in cash.
- U.S. Well Services, Inc. (NASDAQ:USWS) jumped 29.6% to $3.1099 in sympathy with the price of oil amid increased demand and limited supply.
- EZFill Holdings Inc. (NASDAQ:EZFL) surged 17% to $4.0790 after the company announced it has purchased 33 additional fuel trucks, more than tripling the size of its delivery fleet.
- Blue Apron Holdings, Inc. (NYSE:APRN) gained 16.2% to $7.95.
- Gaotu Techedu Inc. (NASDAQ:GOTU) rose 16% to $3.9250.
- Ocular Therapeutix, Inc. (NASDAQ:OCUL) surged 15% to $11.21. Traders circulated Oct. 7 FDA approval for the company’s Dextenza.
- Katapult Holdings, Inc. (NASDAQ:KPLT) rose 13.2% to $5.18. Katapult Holdings became an Accelerate partner in the Adobe Exchange Program.
- DatChat, Inc. (NASDAQ:DATS) gained 13% to $13.24.
- TETRA Technologies, Inc. (NYSE:TTI) rose 12.8% to $3.86 in sympathy with the price of oil amid increased demand and limited supply.
- Innoviz Technologies Ltd. (NASDAQ:INVZ) gained 12.3% to $5.22.
- Willamette Valley Vineyards, Inc. (NASDAQ:WVVI) surged 11.3% to $14.25.
- Nutriband Inc. (NASDAQ:NTRB) shares gained 10.5% to $7.40 after dropping over 14% on Friday.
- Trevi Therapeutics, Inc. (NASDAQ:TRVI) gained 10% to $1.33 after the company filed Friday to withdraw its offering of shares.
- Matinas BioPharma Holdings, Inc. (NASDAQ:MTNB) rose 8.5% to $1.1501.
- Liquidia Corporation (NASDAQ:LQDA) rose 7.9% to $7.40 after the company received favorable ruling in Inter Partes Review against United Therapeutics patent.
- AIkido Pharma Inc. (NASDAQ:AIKI) shares rose 6.8% to $0.9289. HC Wainwright & Co. initiated coverage on AIkido Pharma with a Buy rating and announced a price target of $2.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Check out these big penny stock gainers and losers
Losers
- Cipher Mining Inc. (NASDAQ:CIFR) shares dropped 18.8% to $6.41.
- AeroCentury Corp. (NYSE:ACY) shares fell 14% to $52.44.
- SecureWorks Corp. (NASDAQ:SCWX) shares declined 13.3% to $20.13.
- Voyager Therapeutics, Inc. (NASDAQ:VYGR) dropped 11.3% to $4.92 after jumping around 45% on Friday.
- PagSeguro Digital Ltd. (NASDAQ:PAGS) fell 11.1% to $32.51 after dropping 19% on Friday.
- MeaTech 3D Ltd. (NASDAQ:MITC) dropped 10.3% to $7.62. Meatech 3D recently said it is partnering with a collective led by Ashton Kutcher and Guy Oseary, together with strategic players like Effie Epstein, to accelerate growth in developing, commercializing cultured meat production technologies.
- eFFECTOR Therapeutics, Inc. (NASDAQ:EFTR) fell 9.7% to $10.69. eFFECTOR Therapeutics, in collaboration with Baylor College of Medicine, recently announced the presentation of new positive data for zotatifin in animal models of triple-negative breast cancer (TNBC).
- Hyliion Holdings Corp. (NYSE:HYLN) dropped 9% to $7.11 after UBS downgraded the stock from Neutral to Sell and lowered its price target from $14 to $5.
- BEST Inc. (NYSE:BEST) fell 8.2% to $1.8997.
- Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) dropped 7.5% to $9.56.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.